Tag Archives: study

Bartenders Win! And Improve Their Health in Wisconsin by 36 Percent – Skol!

For what it’s worth: Smoking can lead to really bad stuff.  I know.  I smoked forty years and enjoyed every cigarette.  When I ended up hospitalized and non-smoking that enjoyment turned into a craving I’d never felt before and the craving for a cigarette became agony when I stopped smoking in 1997.  I learned what addiction really means to a drug addict.  Anyone who thinks smoking can’t become an addiction – talk to me.

This study from the University of Wisconsin showed bartenders (36 %) improved their health after the statewide ban on smoking in public places.


Study shows statewide law associated with improved bartender health.

March 14, 2011

Study shows decreases in secondhand smoke exposure and respiratory symptoms

The Impact of Wisconsin’s Statewide Smoke-Free Law on Bartender Health and Attitudes, a study of 531 Wisconsin bartenders before and after Wisconsin enacted its statewide smoking ban, shows eight smoking-related upper respiratory health symptoms were reduced by as much as 36 percent. A baseline survey was conducted two months before the ban went into effect, with a follow-up survey conducted three to six months after the state law. The study included urban and rural areas of Wisconsin and was limited to bartenders who worked in establishments that allowed smoking before the law and were smoke-free after the statewide ban.

Learn more about Tobacco Surveillance and Evaluation Research conducted by CUIR in collaboration with Wisconsin’s Tobacco Prevention and Control Program.


…thanks for reading…. Sharon O’Hara

Another Study, Another Look at Pot

A blogger recently sent the following to counter the first study.  I don’t know but we need to look at all sides of any issue.

Schizophr Res. 2009 Sep;113(2-3):123-8. Epub 2009 Jun 27.

Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005.

Frisher M, Crome I, Martino O, Croft P.

Department of Medicines Management, Keele University, Staffordshire, UK. m.frisher@keele.ac.uk


A recent systematic review concluded that cannabis use increases risk of psychotic outcomes independently of confounding and transient intoxication effects. Furthermore, a model of the association between cannabis use and schizophrenia indicated that the incidence and prevalence of schizophrenia would increase from 1990 onwards. The model is based on three factors: a) increased relative risk of psychotic outcomes for frequent cannabis users compared to those who have never used cannabis between 1.8 and 3.1, b) a substantial rise in UK cannabis use from the mid-1970s and c) elevated risk of 20 years from first use of cannabis. This paper investigates whether this has occurred in the UK by examining trends in the annual prevalence and incidence of schizophrenia and psychoses, as measured by diagnosed cases from 1996 to 2005. Retrospective analysis of the General Practice Research Database (GPRD) was conducted for 183 practices in England, Wales, Scotland and Northern Ireland. The study cohort comprised almost 600,000 patients each year, representing approximately 2.3% of the UK population aged 16 to 44. Between 1996 and 2005 the incidence and prevalence of schizophrenia and psychoses were either stable or declining. Explanations other than a genuine stability or decline were considered, but appeared less plausible. In conclusion, this study did not find any evidence of increasing schizophrenia or psychoses in the general population from 1996 to 2005.

PMID: 19560900 [PubMed – indexed for MEDLINE]


More later… Sharon O’Hara

Indoor Polution Beat Smoker Caused COPD in India Study

Greeting!  Indoor pollution (Outdoor pollution too!) kills and the recent study out of India shows that “At least 93 per cent of those who had COPD were nonsmokers,” says Dr Sundeep Salvi, coordinator of the Chest Research Foundation (CRF).

Out of 3,000 people randomly selected for the study, 210 suffered from COPD.

Chest Research Foundation in collaboration with the KEM Hospital, Pune, and the Imperial College, London, UK, conducted one of the largest COPD prevalence studies in a span of two and a half years and released the data on the eve of World COPD Day on November 17.

You don’t have to be a smoker to suffer from Chronic Obstructive Pulmonary Disease (COPD). Indoor air pollution is enough for one to contract the infection, says the first-of-its-kind study conducted at 22 villages of Pune.

Out of 3,000 people randomly selected for the study, 210 suffered from COPD. “At least 93 per cent of those who had COPD were non smokers,” says Dr Sundeep Salvi, coordinator of the Chest Research Foundation (CRF).

Chest Research Foundation in collaboration with the KEM Hospital, Pune, and the Imperial College, London, UK, conducted one of the largest COPD prevalence studies in a span of two and a half years and released the data on the eve of World COPD Day on November 17.

Dr Sundeep Salvi from CRF, Dr Sanjay Juvekar from KEM Hospital and Dr Peter Barnes from UK spearheaded the study. Salvi said the country requires a national COPD control programme.

The study used a standardised respiratory health questionnaire and spirometry (lung function test that diagnoses COPD). The prevalence of COPD was found to be 6.9% (5.6% amongst females and 8% amongst males).

Among those identified to have COPD, only 7% were smokers and 93% were never smokers, indicating that smoking is clearly not the most important risk factor for COPD in India. More importantly, 23% of the COPDs occurred in age group less than 40 years, which has not been reported earlier, says Salvi.

It has always been believed that COPD starts occurring after 40 years and above in people who have smoked for over 15-20 years. But in India, indoor air pollution seems to be the most important cause so the disease occurs in earlier age groups as well because of exposures from childhood, he explained.

According to a report published by the Maharashtra State Health Resource Centre in March 2010 that examined the top 10 causes of death in Maharashtra, COPD stood out as the number one cause of death. More than 5,50,000 people die due to COPD in India and the country needs a National COPD Control Programme if the numbers of deaths and suffering caused by COPD has to be reduced, he added.


A COPD wet ride to Silverdale and back…

Norway’s Sigrid Ekran – Rookie of the Year – 2007 Iditarod… Anchorage, Alaska
COPD and Rosemaling go everywhere.

Hope to see you all later today – 1:30 in the Rose Room, Silverdale Harrison for World COPD Day 2010!

More later… Sharon O’Hara

$150,000. Yearly Lung Drug for One Patient. P.S. Does It Work?!

When is COPD not COPD?
Why does a special group measuring only 1% of all COPDers (4th leading cause of death in the U.S), get a drug costing $150,000. Per patient, per year and ongoing research. while the other 99% of COPDers get – nothing.in research dollars?

A regular COPDer should pray they turn into one of the 1% group – because there is help out there for that 1% COPD.
The two national COPD support groups were organized and are run by the same 1% group of COPDers. – alpha-1 folks..
Why the discrepancy in treatment interest by a leading respiratory hospital?

COPDers…it is NOT OKAY that a small group of us gets research dollars into real treatments for their COPD (keeps their FEV1 from dropping the study disproved)
The fact is my FEV1 numbers stayed the same for years WITHOUT a $150,000 drug.

We seem to be funding this gross negligent misuse of public funds on a small group of folks while nothing is helping the other 99% of us….no research.

National Jewish is the leading respiratory hospital in the country and has been for 12 years.
I went to their website and looked up the different statements re: alpha-1 and regular COPD.

I then called National Jewish to ask them to tell me what – specifically- they are doing for COPDers…the other 99%. They – literally – had nothing to say. I listened to silence until I quietly put down my phone.

I will ask again. Why the emphasis on research for the 1% group?

Okay – I will ask. If alpha-1 is genetic – is the majority of the people who have it Jewish?


Alpha-1 Antitrypsin Deficiency Program

Alpha-1 Antitrypsin Deficiency (sometimes shortened to Alpha-1) is a hereditary condition that can cause liver disease in infants, children, and adults and can also lead to lung disease in adults.

National Jewish Health is one of the best places in the world to be treated for the adult lung and liver disease caused by Alpha-1. Our doctors have every necessary tool at their fingertips to diagnose and treat this condition. While we do not treat infants or children with Alpha-1 liver disease, we have a close working relationship with The Children’s Hospital in Denver and will make a referral to the appropriate pediatric liver specialist.

Alpha-1 is one of the most common inherited disorders and accounts for about 1 percent of all COPD (chronic obstructive lung disease) in the United States. Research is constantly being done to develop new therapies. Doctors at National Jewish Health have been involved in virtually every new drug evaluated for Alpha-1.

Currently trials are underway or planned to evaluate inhaled therapies and gene therapy for the condition. Our doctors and researchers are always looking for new ways to manage and treat Alpha-1 and other chronic lung diseases.

Doctors at National Jewish Health follow one of the largest groups of Alpha-1 patients in the world. The program here has been devoted to the care of families with Alpha-1 since 1981.

Since Alpha-1 is a genetic condition, we invite all immediate family members to participate in the initial visit, if possible.


COPD Program
The COPD Program offers comprehensive, individualized care for people with chronic obstructive pulmonary disease (COPD) including emphysema and chronic bronchitis.

As the region’s only full-service program, our goal is to help patients manage their disease effectively and to live full and active lives.

The COPD Program offers:
• Unique, collaborative approach proven to enhance quality of life.
• Personalized care plan and individualized take-home binder for every patient.
• Cutting edge diagnostic testing and latest treatments for COPD.
• Nutritional counseling.
• Specialized pulmonary and physical rehabilitation programs.
• Personalized education and group classes.
• Behavioral health and psychosocial services.
• Evaluation for potential lung volume reduction surgery (LVRS) and lung transplant.

Dedicated Team of Experts
The COPD program team of specialists are dedicated to the goal of helping people with COPD “take charge” of their breathing and regain or maintain control of their lives. We are here to partner with you to manage your lung disease in the best way possible. People with COPD can lead active and full lives.

At each visit, you will meet with physicians and/or nurse practitioners who are experts in the field of COPD.
A comprehensive personal COPD plan will be created. This plan will help you manage your COPD, with a focus on maximizing your respiratory health through education, rehabilitation, nutrition and medications. We will consider any other medical conditions or special needs you may have, and you will have appointments with other healthcare professionals. They will address medical and lifestyle issues that impact your quality of life.

More later… Sharon O’Hara

Sarcoidosis 2010 Schedule and Research Study

Sarcoidosis in our area has a great following of dedicated Sarcoidosis patient volunteers who work hard to share the latest research information to benefit us, the Puget Sound Sarcoidosis’ites.
For those unfamiliar with Sarcoidosis:
Sarcoidosis Research Study
Pulmonary Sarcoidosis Treatment Trial
If you have been diagnosed with sarcoidosis of the lung, you may be eligible to participate in a study at the NIH Clinical Center. The purpose of this study is to determine if a widely used cholesterol-lowering agent can decrease the amount of prednisone (steroids) required to manage your illness. Eligible patients will receive a comprehensive evaluation at the Clinical Center in Bethesda, Maryland.

There is no cost to you for travel or medical testing.

For further information, please contact our research coordinator, toll free, at 1-877-NIH-LUNG (1-877-644-5864), e-mail: LungStudy@nhlbi.nih.gov, or you may call Sandra MacDonald, RN at 301-451-4899. Alternatively, you may reach the NIH Patient Recruitment and Public Liaison Office via TTY 1-866-411-1010.

Following is the 2010 Sarcoidosis Support Group Meeting Schedule for the Puget Sound area.

Most meetings are held in the BAKER Room at Puyallup’s Good Samaritan Hospital…. 1:00pm – 3:00pm.

407 14TH AVENUE SE – Puyallup
Baker Room – 1:00pm – 3:00pm


JANUARY – Saturday, 9th 1:00pm – 3:00pm

FEBRUARY – No Meeting
MARCH – No Meeting

APRIL – Saturday, 10th
1:00pm -3:00 pm

MAY – No Meeting
JUNE – No Meeting

JULY – Saturday, 10th
PICINIC at the Short Home
1:00pm – 3:00pm

AUGUST – No Meeting
SEPTEMBER – No Meeting

OCTOBER – Saturday, 9th
1:00pm – 3:00pm

NOVEMBER – No Meeting

DECEMBER – Saturday, 11th
1:00pm – 3:00pm



Lynn Short, Executive Director
Sarcoidosis Networking Association
5302 South Sheridan Avenue
Tacoma, Washington 98408 USA

More Later… Sharon O’Hara

University of Washington’s School of Nurses and COPDers Begin A New Dance

Hi COPDers…. The University of Washington’s #1 rated School of Nursing  in the nation invites us to  read the following description for a new online study.   Enjoy! Talk to you later, Sharon O”Hara

Your Views on Participating in an Internet-based Study of

Physical Activity Patterns and Risk of Chest Infections


Our research group at the University of Washington is interested in studying how different patterns of physical activity put patients with COPD at risk of chest infections.  In order answer this question, we need to study several hundred patients with COPD over an extended period of time.  The most efficient way of doing this is to use the Internet and not require research participants come to a clinical center.

We are asking for your feedback on the feasibility of doing such a study and greatly appreciate your honest input. This 10-minute survey is completely anonymous.  We cannot link responses back to you.  The results will be reported in aggregate form and will not identify you individually. Participation in this survey is voluntary and you are free to skip any questions. Completion of this survey will imply your consent to participate.

Survey Link: https://catalysttools.washington.edu/webq/survey/hqn/81043

If you have any questions or comments about this study, we would be happy to talk with you. Please contact either Dr. Huong Nguyen (HQN@u.washington.edu; 206-543-8651) or Dr. Vincent Fan (vfan@u.washington.edu; 206-764-2292). Please remember that we cannot guarantee the confidentiality of email communication.

For additional rights about giving consent or your rights as a participant in this study, please feel free to contact the University of Washington Institutional Review Board Office at hsdinfo@u.washington.edu or via phone at (206) 543-0098 or via fax (206) 543-9218.

Our sincere appreciation for your time in completing this survey,

Huong Nguyen, PhD, RN

Assistant Professor

University of Washington

Vincent Fan, MD, MPH

Assistant Professor

University of Washington

Arthritis Folks Move On

Supervised exercise for Rheumatoid Arthritis patients can show dramatic improvement in their quality of life, according to a recent study presented in Copenhagen at the Annual Congress of the European League Against Rheumatism. ScienceDaily reported the announcement, June 23, 2009.

Led by Dr. Miguel Souse of Instituto Portugues de Phematology in Lisbon, Portugal, the three-month study revealed, “”When joints are stiff and painful, proactively taking exercise might seem undesirable for people with RA. However, our study has demonstrated that regular and supervised moderate aerobic workouts and strengthening exercises may be extremely beneficial for both a patient’s physical and mental health, with a corresponding effect on quality of life. The challenge for physicians is to provide suitable motivation and reassurance to their RA patients in order that they initiate and stick with such a programme.”

If regular bone on bone hip joints react the same as RA, it is easy to be reluctant IF the patient is worried the bones will get ground down further.

What do the bone doctors think and who leads such ‘supervised exercise’ here in Kitsap County – anyone?

The percentages of reported improvement are dramatic… such as 55% improvement in the “sit and stand test * 62% patients reported less need for steroid use * 33% improvement in daily physical functioning, such as dressing and walking. * 40% improvement in the Depression Anxiety Stress Scales is significant.

The study patients worked out three times a week for 50 -60 minutes of aerobic and strengthening exercises for three months.

I have many questions to ask at the annual Arthritis Foundation Conference next month – free to the public.

The Free Public Symposium, “Taking control of Arthritis Together” is Thursday, July 23, 2009 from 08:30 am to 12:30 pm at the Shoreline Conference Center, 18560 1st Ave. NE, Shoreline, WA.

The program includes a free osteoporosis screening by the Washington Osteoporosis Coalition and includes such notables as:

Basia Belza, PhD. RN – Aljova Endowed Professor in Aging University of Washington School of Nursing.
Julie L Carkin, MD – The Seattle Arthritis Clinic Director, Osteoporosis Services Northwest Hospital
Larry Wienkers, PharmD
Sue Romanick, MD – Rheumatologist, Private Practice
Jane Hoyt Buckner, MD – Associate Member Director, Translational Research Benaroya Research Institute
Diane Sowinski – Patient Advocate, Personal Trainer & Arthritis Veteran
Angelika Burns – Personal Trainer, Will Tree Fitness Wellness Coordinator, Bayview Wellness Center

If anyone is interested in carpooling or needs a ride, let me know.

Pre-Registration is required.
Contact Annie Rehn at (800) 746-1821 ext. 101 or arehn@arthritis.org
Have a great week – more later.– keep moving.… Sharon